scholarly journals Intravenous fluids in hot pre-hospital environments: Thermal and physical stability of normal saline after exposure to simulated stress conditions

Author(s):  
Ousama Rachid ◽  
Mohammed Akkbik ◽  
Ahmed Makhlouf ◽  
Ayad Moslih ◽  
Loua Al Shaikh ◽  
...  
2017 ◽  
Vol 24 (2) ◽  
pp. 117-122 ◽  
Author(s):  
Seyed Jalal Madani ◽  
Fariba Araste Fard ◽  
Hamidreza Karimi-Sari ◽  
Mohammad Hossein Khosravi ◽  
Abbasali Delavari

2021 ◽  
Vol 18 (10) ◽  
pp. 2003-2010
Author(s):  
Irfan Aslam ◽  
Naveed Akhtar

Purpose: To develop, optimize and characterize a topical (W/O) emulsion containing 4 % Ficus religiosa extract for cosmeceutical purposes. Methods: The ethanol extract of Ficus religiosa was obtained by Soxhlet method. Various formulations were developed using paraffin oil, emulsifier (Abil®-EM 90) and purified water at different proportions, and their physical stability was assessed under different stress conditions, to enable selection of the most stable formulation. The optimized formulation based on stability studies was chosen for evaluation of different physical properties, i.e., color, liquefaction, phase separation, centrifugation, pH, droplet size and rheology, under accelerated conditions for 12 weeks. Results: The optimized formulation (F4) contained ethanol extract (4.0 %), Abil®-EM 90 (3.5 %), paraffin oil (14.0 %) and purified water (78.5 %), and remained stable on centrifugation under all stress conditions. The pH of the formulation remained within the specified range for human skin pH i.e. 4.5 – 6.0, and droplet size of dispersed phase also persisted within the size range of macroemulsion (1 – 100 μm) throughout the study period. Rheological properties of the formulation showed shear thinning response, and flow index value less than 1 resulted in pseudoplastic flow of emulsion. Conclusion: These results suggest that the optimized emulsion system was stable and can serve as a good medium for topical delivery of various natural substances.


Author(s):  
Purav Mody ◽  
Shu-Xia Li ◽  
Kumar Dharmarajan ◽  
Nancy Kim ◽  
Kelly Strait ◽  
...  

Administration of Intravenous Fluids in Patients Hospitalized with Heart Failure Background: Administration of intravenous (IV) fluids to patients with acute decompensated heart failure (HF) may worsen pulmonary congestion or hemodynamic status. However, little is known about the use of IV fluids in clinical practice. We examined the frequency and volume with which commonly used IV fluid preparations are used among inpatients with HF as well as the association of these treatment patterns with diuretic use and length of stay (LOS). Methods: We identified all hospitalizations in 2009-2010 with a principal discharge diagnosis of heart failure from the Premier, Inc. hospitals. In order to capture inappropriate therapy with intravenous fluids, we limited our study period to the initial two days, a period during which most HF patients undergo diuresis for fluid overload. We excluded patients with a potential indication for fluid resuscitation (concomitant therapy with vasopressors or inotropes, undergoing invasive procedures, or having secondary diagnosis of bleeding, sepsis or anaphylaxis). We also excluded hospitalizations with age < 18 yrs, < 3 day LOS, transfer-ins, and hospitals with < 25 HF cases. We calculated the administration frequency and volume of commonly used IV fluids (normal saline, half normal saline, 5% dextrose, and Lactated Ringer’s), the percentage of patients receiving concomitant therapy with loop diuretics, and the average LOS associated with administration of each of the four fluids. Results: Among 195,652 hospitalizations, 25% (48,611) were administered at least one of the four IV fluids. Normal saline was the most commonly administered fluid (19.4% of hospitalizations), followed by 5% dextrose (6%), half normal saline (2.2%), and Lactated Ringer’s (0.2%). The median volume of fluid administration over the first two days was 1,000 ml (IQR: 250, 1250). Eighty-nine percent of patients receiving fluid therapy received concomitant loop diuretics. Increasing median LOS was noted with increasing fluid volumes across all four individual IV fluid categories (see Table). Conclusion: A substantial proportion of patients hospitalized with HF receive a considerable volume of intravenous fluid during their first 2 hospital days; normal saline was the most commonly administered formulation. Loop diuretic use was very common in those receiving IV fluids. Greater understanding of the concomitant use of intravenous fluids and diuretics and their relation to length of stay may provide an opportunity to improve quality of care.


1977 ◽  
Vol 11 (11) ◽  
pp. 646-649 ◽  
Author(s):  
Jerry L. Bauman ◽  
John K. Siepler ◽  
John Fitzloff

Free phenytoin crystallization in various commercially available intravenous solutions was investigated. Phenytoin determinations were completed at various time periods, before and after filtration, by spectrophotometric analysis. Phenytoin was found to produce a more stable solution in normal saline and lactated Ringer's solutions than in 5 percent dextrose in normal saline or 5 percent dextrose in water. The pH differences between commercial phenytoin sodium for injection and the various intravenous fluids were felt to be the major factor responsible for free phenytoin crystallization. It was concluded that phenytoin sodium admixture to normal saline or lactated Ringer's solution can indeed be used clinically, with precautions. The variations in pH of available intravenous solutions make apparent the need for careful inspection of sodium phenytoin admixtures and for such infusions to be started immediately after admixture.


2018 ◽  
Vol 103 (2) ◽  
pp. e2.23-e2
Author(s):  
Andrew Wignell

AimsPlasma-Lyte 148 is a balanced, crystalloid intravenous fluid which is both calcium-free and isotonic. It has been demonstrated to reduce the risk of hyperchloraemic metabolic acidosis and iatrogenic hyponatraemia seen with use of normal saline and hypotonic solutions respectively. Investigating the compatibility of Plasma-Lyte 148 and Plasma-Lyte 148+5% gucose with morphine, midazolam, fentanyl, ketamine, clonidine, aminophylline, salbutamol and furosemide will provide vital data to facilitate the introduction of these fluids into routine paediatric practice.MethodChemical stability was assessed by high performance liquid chromatography (HPLC) using the ‘Hewlett Packard (Agilent) 1100’ HPLC system. A gradient method with 20 mM ammonium carbonate (A) and acetonitrile (B) mobile phases and an ‘ACE Excel 3 SuperC18’ column was used. The flow rate was set to 0.03 ml/min, temperature to 40°C and injection volume for all drug admixtures to 5 µL apart from ketamine (4 µL) and furosemide (1 µL). Physical stability was assessed by observation of precipitate formation or colour change. Six repeats of each IV fluid and drug mix were assayed at three time points: 0, 2 and 24 hours. pH changes were measured using Fisherbrand Hydrus 300. Normal saline and 5% glucose were used as controls for all experiments.ResultsNo precipitate formed in any of the samples. Chemical stability was defined as <5% concentration change. All examined therapeutic agents were stable at 2 and 24 hours relative to control solutions. Relative to starting concentration, all drugs except midazolam were stable to ±3%. Midazolam showed similar variation in concentration with all four fluids. All combinations remained in a safe peripheral administration pH range of 5–9. Plasma-Lyte 148 admixtures were found have a pH closest to that of the blood.ConclusionCompared to standard diluents, the tested therapeutic agents are chemically and physically stable for 24 hours at the concentrations measured, and are all stable at commonly encountered Y site concentrations, when diluted with Plasma-Lyte 148 or Plasma-Lyte 148+5% glucose. All are pH stable and all are suitable for peripheral administration.


Author(s):  
Vijay Agarwal ◽  
Devendra Rathore ◽  
Meenakshi Bajpai

In this research work, the effects of nonionic stabilizers on the physical stability of drug nanosuspensions were investigated. For this purpose five nonionic polymers (hydroxypropylmethyl cellulose (HPMC), Hydroxypropyl cellulose (HPC), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP) and pluronic F68) and esomeprazole were selected as stabilizers and drug candidate, respectively. All the nanosuspensions were prepared using bottom up approach. The potential of Ostwald ripening for the nanosuspensions was investigated by subjecting them to various stress conditions such as storage at various temperature conditions (15°C, 25°C, 35°C, 45°C), mechanically shaking for 72 hours and fluctuation in storage temperature. All the polyvinylpyrrolidone and hydroxypropyl cellulose based formulations that were stored under different stress conditions exhibited the increase in particle size. In other cases the highest increase in mean particle size was observed at 45oC, followed by 35°C. Samples stored at 15°C and 25°C did not exhibit the significant changes in particle size. The HPMC 1 formulation stored at 45°C, exhibited a steep increase in particle size, probably due to desolvation of the HPMC molecules at this temperature and subsequent loss of stabilization of the nanoparticles. However, in case of HPMC 2 and HPMC 3 formulations (stored at 45°C), the gradual increase in particles size was obtained. This trend of increase in particle size was attributed to presentation of excess amount of HPMC. Powder X-ray diffraction analysis confirmed that all the prepared nanosuspensions were in crystalline state. Hence, physical treatments and other factors did not change the crystalline state of nanosuspensions. To Confirm the crystalline state of those samples which were undergo for 3 cycles of temperature fluctuation, the DSC (Differential scanning calorimetry) analysis was performed, and compare with raw drug. Esomeprazole exhibited the melting endotherm at an onset temperature of 178.1°C and a peak temperature at 185.31°C. The thermogram revealed that crystalline state of raw drug was not changes but the melting peak drifted slightly due to presence of stabilizers.


Crisis ◽  
2012 ◽  
Vol 33 (2) ◽  
pp. 106-112 ◽  
Author(s):  
Christopher M. Bloom ◽  
Shareen Holly ◽  
Adam M. P. Miller

Background: Historically, the field of self-injury has distinguished between the behaviors exhibited among individuals with a developmental disability (self-injurious behaviors; SIB) and those present within a normative population (nonsuicidal self-injury; NSSI),which typically result as a response to perceived stress. More recently, however, conclusions about NSSI have been drawn from lines of animal research aimed at examining the neurobiological mechanisms of SIB. Despite some functional similarity between SIB and NSSI, no empirical investigation has provided precedent for the application of SIB-targeted animal research as justification for pharmacological interventions in populations demonstrating NSSI. Aims: The present study examined this question directly, by simulating an animal model of SIB in rodents injected with pemoline and systematically manipulating stress conditions in order to monitor rates of self-injury. Methods: Sham controls and experimental animals injected with pemoline (200 mg/kg) were assigned to either a low stress (discriminated positive reinforcement) or high stress (discriminated avoidance) group and compared on the dependent measures of self-inflicted injury prevalence and severity. Results: The manipulation of stress conditions did not impact the rate of self-injury demonstrated by the rats. The results do not support a model of stress-induced SIB in rodents. Conclusions: Current findings provide evidence for caution in the development of pharmacotherapies of NSSI in human populations based on CNS stimulant models. Theoretical implications are discussed with respect to antecedent factors such as preinjury arousal level and environmental stress.


Planta Medica ◽  
2014 ◽  
Vol 80 (10) ◽  
Author(s):  
F Nabbie ◽  
O Shperdheja ◽  
J Millot ◽  
J Lindberg ◽  
B Peethambaran

Sign in / Sign up

Export Citation Format

Share Document